All Posts By

Smartkarma Daily Briefs

Daily Brief Singapore: Talkmed, SGX Rubber Future TSR20, Asia High Yield Bond Index, Capitaland Integrated Commercial Trust, Q & M Dental Group (Singapore) and more

By | Daily Briefs, Singapore

In today’s briefing:

  • TalkMed (TKMED SP)’s Super Clean Scheme
  • Indonesia Defies Headwinds To Post Robust Rubber Exports In Early 2025
  • Asian Bond Monitor: Asian Bonds for the Upcoming Recession
  • REIT Watch – Best performing S-REITs post double digit total returns in H1
  • REITs and Tech led Net Institutional Inflows, as Frencken Chair and DHLT CEO Raised their Stakes


TalkMed (TKMED SP)’s Super Clean Scheme

By David Blennerhassett

  • On the 23 Dec 2024, tertiary health care provider TalkMed (TKMED SP)  announced an Offer, by way of a Scheme, from Tamarind Health at S$0.456/share, a 20% premium to undisturbed.  
  • Tamarind is a Singaporean-based, pan-Asian oncology-focused group. As part of the deal, Temasek-backed 65 Equity Partners will subscribe for new shares in Tamarind.
  • The Composite Document is now out, with a Court Meeting on the 15th July, and expected payment around the 29th August. The IFA (KPMG) says “fair & reasonable“. 

Indonesia Defies Headwinds To Post Robust Rubber Exports In Early 2025

By Vinod Nedumudy

  • Price edge and stable grades help Indonesia stage a good show  
  • US demand strengthens despite Trump tariffs  
  • China demand softens, Japan slides as tariffs take effect  

Asian Bond Monitor: Asian Bonds for the Upcoming Recession

By Warut Promboon

  • Inflation will remain sticky but we expect the recession headline to keep a lid on consumer spending which should also limit the possibility of a future rate hike.
  • We believe fixed rate bonds should be the instrument of choice toward the end of this year. 
  • Rising default and a lack of growth in developed markets should also bode well for Asian US Dollar (USD) bonds.

REIT Watch – Best performing S-REITs post double digit total returns in H1

By Geoff Howie

  • Top S-REIT performers in H1 2025 include FHT, CICT, First REIT, FCT, and Parkway Life REIT with returns of 10.0-21.4%.
  • Retail investors were net buyers with S$400 million inflow, while institutions were net sellers with S$500 million outflow.
  • Forward dividend yield for FTSE ST REIT Index was 6.4%, with a nearly 4% yield spread to 10-year Singapore Government Bonds.

REITs and Tech led Net Institutional Inflows, as Frencken Chair and DHLT CEO Raised their Stakes

By Geoff Howie

  • Institutions were net sellers of Singapore stocks with a S$248 million outflow, led by STI banks’ S$2.73 billion outflow.
  • United Overseas Bank, DBS Group Holdings, and Oversea-Chinese Banking Corporation led share buybacks, totaling S$69.7 million in consideration.
  • Q & M Dental Group CEO Ng Chin Siau increased his interest to 55.78%, acquiring 7,041,300 shares via Quan Min Holdings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Paladin Energy, Santos Ltd, Nine Entertainment Co Holdings, APA Group, Beetaloo Energy Australia, Ricegrowers Ltd, Canyon Resources and more

By | Australia, Daily Briefs

In today’s briefing:

  • Paladin’s CEO Exit: Cause for Concern?
  • (Mostly) Asia M&A, June 2025 Wrap: Santos, Fuji Corp, Brickworks, Great Eastern, VIOL, Adriatic
  • Nine Entertainment Co Holdings Ltd – The Overnight Report: Let’s Party Like It’s 1999
  • APA Group – Australian Broker Call *Extra* Edition – Jun 30, 2025
  • Beetaloo Energy Australia – Traditional Owners’ Consent Secured
  • Ricegrowers Ltd – Branded sales growth drives earnings
  • Ricegrowers Ltd – SunRice RaaS Interview Transcript
  • Canyon Resources — Further development progress


Paladin’s CEO Exit: Cause for Concern?

By Money of Mine

  • Ian Purdy departing Paladin Energy, with Paul Hamburrow stepping up as new CEO
  • Paladin Energy facing challenges and controversies during Purdy’s tenure
  • Potential implications and scrutiny surrounding Purdy’s departure and the future of the company under new leadership

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


(Mostly) Asia M&A, June 2025 Wrap: Santos, Fuji Corp, Brickworks, Great Eastern, VIOL, Adriatic

By David Blennerhassett

  • For June 2025, 11 new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$29bn.
  • The average premium for the new transactions announced (or first discussed) in June was ~39%, with a year-to-date average of 47%.
  • The average premiums for transactions in 2024 (129 transactions), (2023 (117), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) were 43%, 39%, 41%, 33%, 31%, and 31%.



Beetaloo Energy Australia – Traditional Owners’ Consent Secured

By Research as a Service (RaaS)

  • Beetaloo Energy Australia Limited (ASX:BTL) is a gas development company, with onshore Northern Territory (NT) gas exploration and development assets.
  • BTL has the largest tenement position in the highly prospective Greater McArthur Basin, which includes the Beetaloo Sub-basin.
  • The company has announced it has secured the consent (‘Consent’) for the sale of gas from EP187 (Carpentaria Pilot Project) after On Country meetings with the traditional owners across 24-25 June.

Ricegrowers Ltd – Branded sales growth drives earnings

By Research as a Service (RaaS)

  • Ricegrowers Limited, trading as SunRice (ASX:SGLLV), has released its FY25 results, delivering EBITDA of $147.7m (+4% above the PCP and in line with RaaS estimates) and NPAT of $69.5m (-6% due to a higher tax rate and 3% below RaaS estimates).
  • Divisionally, Riviana (FX pressures) and Corporate (continued mill-out rate issues) were below our forecast while the other divisions were well above our forecasts, driven by margin mix (branded sales) and a cost/efficiency focus.
  • The fully franked final dividend of $0.50/share was above our forecast while the Dividend Reinvestment Plan (DRP) has been reintroduced, this time partially underwritten.

Ricegrowers Ltd – SunRice RaaS Interview Transcript

By Research as a Service (RaaS)

  • This is a transcript of the video interview in which RaaS interviews SunRice Group CFO Dimitri Courtelis following the company’s FY25 results.

Canyon Resources — Further development progress

By Edison Investment Research

Canyon Resources has provided an update on development activities at its flagship Minim Martap bauxite project in Cameroon. With the recently secured debt funding and first proceeds from the option exercise by its core shareholder Eagle Eye Asset Holdings, the company is in a strong position to continue with the accelerated project development. It remains on track for first ore production in early 2026 and first bauxite shipment in H1 CY26.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Shift Up, Easy Bio, Samsung Electronics and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Sizing up September’s KOSPI Size Index Migration Names
  • Korea Small Cap Gem #37: Easy Bio Inc
  • Chips News: GPU, CPU in China. Qualcomm Going to Samsung Maybe, Microsoft Accelerator Delayed.


Sizing up September’s KOSPI Size Index Migration Names

By Sanghyun Park

  • Early take based on avg daily mkt cap: 5 MID→LARGE, 6 LARGE→MID. Count mismatch due to LG CNS likely making a direct jump into LARGE post-March IPO.
  • Local insto-driven moves remain tradable — in the March reshuffle, price action started from T–2M, with strongest returns in the T–1M window.
  • With cap gaps near historical norms, it’s time to pre-position around top/bottom cutline names — then scale up into borderlines as we move into the T–1M window.

Korea Small Cap Gem #37: Easy Bio Inc

By Douglas Kim

  • Easy Bio Inc is one of the leaders specializing in piglet feed and animal feed additives in Korea. 
  • The company completed an excellent M&A of a company in the US called Devenish Nutrition in February 2024 for 88 billion won. 
  • If we assume a P/E of 10x and apply this on consensus net profit estimate of 36.3 billion won in 2026, this would suggest market cap of 363 billion won. 

Chips News: GPU, CPU in China. Qualcomm Going to Samsung Maybe, Microsoft Accelerator Delayed.

By Nicolas Baratte

  • Lisuan new GPU is a first step, but performance far behind AMD/Nvidia. Loongson new server CPU looks good, close to Intel chip of 2021. Major bottleneck remains SMIC 7nm capacity.
  • Qualcomm looks close to qualifying Samsung’s 2nm to manufacture Snapdragon 8 Elite 2. This would imply a major yield breakthru for Samsung.
  • Microsoft ARM CPU Maia is in production, but its AI accelerator Braga seems delayed significantly – either performance or an architecture rethink.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: SGX Rubber Future TSR20, Medco Energi and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Indonesia Defies Headwinds To Post Robust Rubber Exports In Early 2025
  • Lucror Analytics – Morning Views Asia


Indonesia Defies Headwinds To Post Robust Rubber Exports In Early 2025

By Vinod Nedumudy

  • Price edge and stable grades help Indonesia stage a good show  
  • US demand strengthens despite Trump tariffs  
  • China demand softens, Japan slides as tariffs take effect  

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Medco Energi, Greenko Energy
  • UST yields rose 3-4 bps across the curve on Friday, after US President Donald Trump cut off trade talks with Canada.
  • This unwound yield declines earlier in the day, on the back of weaker than expected personal spending and income data. The yield on the 2Y and 10Y UST advanced 3 bps to 3.75% and 4.28%, respectively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: UK Energy:  Concentrated and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • UK Energy:  Concentrated, Under-Owned, and Out of Focus


UK Energy:  Concentrated, Under-Owned, and Out of Focus

By Steven Holden

  • Active UK funds continue to reduce their exposure to the Energy sector, with positioning falling to near record lows. 
  • The UK Energy sector is dominated by just two names— Shell and BP  —which together account for 90% of the total sector allocation.
  • UK Industrials, Financials, and Consumer sectors have become increasingly dominant, with Energy’s diminished role reflecting a shift in market structure and a redefinition of what drives UK equity portfolios.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: BlackRock, Fortive , NVIDIA Corp, International Game Technology, USD, Hims & Hers Health Inc, Mira Pharmaceuticals , Euronet Worldwide, Carter’s Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • 225: Retirement Planning: What New Legislation Could Mean For Your Retirement Account
  • Fortive or Its Spin-Off Ralliant – Which One Is a Better Buy?
  • Nvidia’s Silent Cloud Takeover: How the AI Chip King is Disrupting Amazon, Google & Microsoft
  • Buy International Gaming Technologies
  • Global FX: Mid-Year Outlook – Tell me something new
  • Hims & Hers Stock Nosedives: The Real Reason Behind the Novo Nordisk Breakup!
  • Weekly Update (AMRZ, UNTC, MEDXF, IGT)
  • MIRA: Data Shows Weight Drop Without Muscle Loss
  • Euronet: Accelerating Money Transfer Growth with 31% Digital Surge & 22 New Market Wins!
  • Carter’s Inc – Carter’s Inc.: Can Retail Strategy Revamp Win Over New Shoppers?


225: Retirement Planning: What New Legislation Could Mean For Your Retirement Account

By The Bid

  • Retirement is a key focus for BlackRock, with half of their assets being retirement related
  • Recent policy changes have expanded access to workplace retirement plans in the US
  • BlackRock and the Bipartisan Policy Center have co-authored a paper with recommendations to increase access to retirement plans and improve best practices for saving and investing for retirement

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Fortive or Its Spin-Off Ralliant – Which One Is a Better Buy?

By Garvit Bhandari

  • Fortive and Ralliant began when-issued trading on June 25, 2025 under the ticker ‘FTV WI’ and ‘RAL WI’. 
  • The regular-way trading will begin on June 30, 2025. Ralliant will trade under the ticker ‘RAL’ and Fortive (ex Ralliant) will continue to trade under the ticker ‘FTV’.
  • As part of the transaction, FTV (ex RAL) will receive $1.15 billion in dividend from Ralliant Corp. RAL will assume debt to pay the cash dividend to FTV.

Nvidia’s Silent Cloud Takeover: How the AI Chip King is Disrupting Amazon, Google & Microsoft

By Baptista Research

  • In recent months, Nvidia has quietly transformed from the undisputed leader in AI semiconductors into a formidable new player in cloud computing.
  • What began with DGX Cloud—launched two years ago as an infrastructure offering focused on AI workloads—has evolved into a full-fledged attempt to reshape how cloud services are consumed and delivered.
  • The latest development is the launch of DGX Cloud Lepton, a marketplace designed to aggregate unused GPU capacity across a network of Nvidia-aligned cloud providers, including CoreWeave, Lambda, and Crusoe.

Buy International Gaming Technologies

By Richard Howe

  • International Gaming Technologies (IGT) is in the process of selling its Global Gaming and PlayDigital segments.
  • The merger arbitrage market implies a high likelihood that this deal closes soon ($14.23 share price for EVRI vs. acquisition price of $14.25).
  • Guidance is the deal could close as soon as July 1, 2025.

Global FX: Mid-Year Outlook – Tell me something new

By At Any Rate

  • Dollar decoupled from US rates and equities, investors expected to chase dollar lower
  • Dollar positioning not as crowded as perceived, global holdings of US equities still large
  • Unlikely for significant repatriation of Japanese foreign bond investments, focus on rebalancing rather than one-way repatriation; implications of upcoming election on Yen uncertain

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Hims & Hers Stock Nosedives: The Real Reason Behind the Novo Nordisk Breakup!

By Baptista Research

  • Hims & Hers Health has found itself at the center of investor turmoil after its high-profile collaboration with Novo Nordisk on FDA-approved weight loss drug Wegovy abruptly ended.
  • The Danish pharmaceutical titan terminated the pact, accusing Hims & Hers of misleading marketing practices and non-compliance with regulations governing compounded drugs—actions it deemed a threat to patient safety.
  • Hims & Hers CEO Andrew Dudum fired back, insisting the company’s compounding approach is legal under FDA rules and accusing Novo Nordisk of leveraging its market dominance to pressure patients toward branded Wegovy.

Weekly Update (AMRZ, UNTC, MEDXF, IGT)

By Richard Howe

  • This week, I recommended a new idea: Buy International Gaming Technologies.

  • If you are interested in buying IGT, I would recommend doing so on Monday.

  • IGT is in the process of selling its Gaming division for $4BN, and the transaction could close as soon as Tuesday, July 1.


MIRA: Data Shows Weight Drop Without Muscle Loss

By Zacks Small Cap Research

  • MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Euronet: Accelerating Money Transfer Growth with 31% Digital Surge & 22 New Market Wins!

By Baptista Research

  • Euronet Worldwide concluded its first quarter of 2025 with several notable achievements and strategic moves that highlight both the strengths and challenges of the company’s diverse business model.
  • The company reported double-digit growth in both operating income and adjusted EBITDA, an 18% increase in operating income compared to the previous year.
  • The growth spanned across all segments, driven by robust performance in transaction processing and foreign exchange activities.

Carter’s Inc – Carter’s Inc.: Can Retail Strategy Revamp Win Over New Shoppers?

By Baptista Research

  • Carter’s, Inc. recently held its first quarter fiscal 2025 earnings call, revealing a mixed performance marked by both challenges and strategic initiatives intended to bolster long-term growth.
  • Under Doug Palladini, the new CEO, Carter’s is gearing towards a reinvigorated strategy aimed at sustainable and accretive growth.
  • His prior experience with brand expansion at Vans suggests an inclination towards focusing on enduring consumer connections and brand loyalty, elements he deems critical for Carter’s path forward.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Mazagon Dock Shipbuilders , Canara Bank, RPSG Ventures Limited, Aditya Birla Fashion and Retail Ltd, Edelweiss Financial Services, HDB Financial Services Ltd, Nesco Ltd, Nuvama Wealth Management, Rajshree Polypack and more

By | Daily Briefs, India

In today’s briefing:

  • AMFI Stock Reclassification Preview (Jun 2025): Active Flows Lead to Passive Flows
  • Relative Value Roundup: Opportunities and Performance Recap of Pair Trades in Asia-Pacific
  • RPSG Ventures: BPO Business Doing Well | Holding Company Discount at 82%
  • Event Driven: ABFRL~ Value Unlocking Through Strategic Demerger
  • Edelweiss: Last 3Y Have Seen Tremendous Shift, Next 2Y Should Be Even Better
  • HDB Financial Services: Float Cap Expansion Sets Stage for Global Index Inclusion
  • Nesco: Weak Q4FY25 Due to Underwhelming Performance in BEC
  • Nuvama: FY25 Ends To Be a Breakout Year
  • RPPL: Strong Q4FY25 | Next 2Y Look Promising


AMFI Stock Reclassification Preview (Jun 2025): Active Flows Lead to Passive Flows

By Brian Freitas

  • We forecast 10 stocks moving from MidCap to LargeCap, 11 stocks moving from LargeCap to MidCap, 10 stocks from SmallCap to MidCap, and 13 stocks from MidCap to SmallCap.
  • From the new listings, 1 stock is expected to be added to Large cap, 2 stocks are expected to be added to Mid Cap, and multiple stocks to Small Cap.
  • There are multiple stocks among the AMFI changes that will be changes for global indices, NIFTY Index, NSE Nifty Next 50 Index and/or Nifty Midcap 150 Index in September.

Relative Value Roundup: Opportunities and Performance Recap of Pair Trades in Asia-Pacific

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlight: Three pair trade opportunities across three markets and two sectors persist.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

RPSG Ventures: BPO Business Doing Well | Holding Company Discount at 82%

By Ankit Agrawal, CFA

  • RPSG Ventures reported a strong Q4FY25 led by the BPO business that has been growing well. BPO revenues grew 3%+ QoQ and 30%+ YoY. EBIT margin has sustained at 11%+.
  • The FMCG business after posting INR 550cr+ annualized revenue run-rate for the past few quarters saw a dip in Q4FY25 with annualized revenue at INR 520cr.
  • The Sports segment reported similar revenue YoY at INR 135cr+, led by part revenue recognition from IPL 2025 that began at end of March, similar to that in 2024.

Event Driven: ABFRL~ Value Unlocking Through Strategic Demerger

By Nimish Maheshwari

  • Aditya Birla Fashion and Retail Ltd (ABFRL IN) demerged its business into two focussed entities, ABLBL(Stable Business) and ABFRL(High growth Business).
  • The separation aligns capital with business maturity isolating cash-generating lifestyle brands from high-growth, capital-hungry verticals like ethnic, luxury, and digital-first.
  • The two entities are targeting a combined INR 30,000 Cr in revenue and 3x cash profit by FY30 through unlocking sharper execution, better capital efficiency, and distinct investor appeal.

Edelweiss: Last 3Y Have Seen Tremendous Shift, Next 2Y Should Be Even Better

By Ankit Agrawal, CFA

  • Edelweiss has executed well over the past three years led by its pivot towards fee-based model. Its asset management businesses have grown rapidly, contributing significantly to the fee income.
  • The credit businesses are still struggling in terms of growth, but they have been pivoted successfully towards the co-lending model and the next couple of years could see significant growth.
  • The insurance businesses are also on track to breakeven over the next couple of years in line with the management’s prior guidance.

HDB Financial Services: Float Cap Expansion Sets Stage for Global Index Inclusion

By Dimitris Ioannidis

  • The free float is estimated to gradually increase from ~15% up to 30% over six months due to the lock-up expiries of Anchor Investors and pre-IPO Shareholders.
  • HDB Financial Services is forecasted to be added to Global All-World in December 2025 following the lock-up expiry of the Anchor Investors.
  • HDB Financial Services has a chance of inclusion in Global Standard in February 2026 following the lock-up expiry of pre-IPO shareholders which can increase free float up to 30%.

Nesco: Weak Q4FY25 Due to Underwhelming Performance in BEC

By Ankit Agrawal, CFA

  • Nesco reported a weak Q4FY25 led by weak performance in the exhibition segment (“BEC”). Revenue in the BEC segment was down -25% YoY and -30% QoQ.
  • On the other hand, the IT Parks segment performed strong. IT Parks segment’s Q4FY25 revenue grew 2% QoQ and 15%+ YoY, led by improved occupancy and rise in rental rates.
  • Typically, the Foods business is linked to the BEC business. However, in Q4FY25, despite weak BEC revenues, the Foods business did well led by the catering business.

Nuvama: FY25 Ends To Be a Breakout Year

By Ankit Agrawal, CFA

  • Nuvama Wealth Management (“Nuvama”) has consistently outperformed expectations throughout FY25 and Q4FY25 was no exception. In particular, the Asset Services sub-segment has been the outlier.
  • The Wealth Management and Asset Management segments continued to perform steadily providing resilience to the platform, despite cyclicality. They saw net inflows despite challenging market conditions during 2HFY25. 
  • Due to market volatility, certain pockets of the investment bank and institutional equities sub-segments saw somewhat muted performance, however, Nuvama fared much better relative to its peers.

RPPL: Strong Q4FY25 | Next 2Y Look Promising

By Ankit Agrawal, CFA

  • Rajshree Polypack (“RPPL”) reported excellent Q4FY25 led by strong growth in injection molding and exports revenue. Exports quarterly revenue grew to INR 20cr vs INR 10cr+ run-rate earlier.
  • Injection molding segment has grown well. It clocked INR 15cr+ in revenue in Q4FY25 vs INR 8cr YoY. For FY25, revenue from injection molding more than doubled to INR 40cr+.
  • Led by growing mix of high-value segments like injection molding, barrier packaging and exports in Q4FY25, EBITDA margin improved to 13.7% vs 13.5% YoY and 12.5% QoQ.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: BayCurrent Consulting , Nippon Concept, Ana Holdings, Sanyo Shokai and more

By | Daily Briefs, Japan

In today’s briefing:

  • Nikkei 225 Index Rebalance Preview (Sep 2025): Potential Adds, Deletes, PAF, Capping & Other Changes
  • Nippon Concept (9386 JP): J-STAR-Sponsored MBO a Done Deal
  • Quiddity JPX-Nikkei 400 Rebal 2025: End-June 2025 Ranks (FINAL EXPECTATIONS)
  • Sanyo Shokai (8011 JP): Q1 FY02/26 flash update


Nikkei 225 Index Rebalance Preview (Sep 2025): Potential Adds, Deletes, PAF, Capping & Other Changes

By Brian Freitas


Nippon Concept (9386 JP): J-STAR-Sponsored MBO a Done Deal

By Arun George

  • Nippon Concept (9386 JP) has recommended a J-STAR-sponsored MBO at JPY3,060, a 37.2% premium to the last close price.
  • The offer is attractive as it represents an all-time high and is above the midpoint of the IFA DCF valuation range.
  • An attractive offer and irrevocables pave the way for deal completion. The tender runs from July 1 to August 13, with payment due on August 20.

Quiddity JPX-Nikkei 400 Rebal 2025: End-June 2025 Ranks (FINAL EXPECTATIONS)

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted capped index composed of 400 constituents.
  • The annual index review takes place in August every year. We look at the latest rankings of potential ADDs/DELs every month.
  • Below is a look at the rankings of potential ADDs/DELs for the JPX-Nikkei 400 August 2025 rebalance based on trading data as of end-June 2025.

Sanyo Shokai (8011 JP): Q1 FY02/26 flash update

By Shared Research

  • Revenue decreased by 5.7% YoY to JPY14.5bn, with operating profit declining by 95.2% YoY to JPY36m.
  • Net income attributable to owners fell 93.9% YoY to JPY36m, with recurring profit down 96.6% YoY to JPY25m.
  • Despite reducing SG&A expenses by JPY400m, cost-control efforts failed to offset gross profit decline from lower revenue.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Lens Technology A/H Listing – Pricing Looks Decent and more

By | Daily Briefs, ECM

In today’s briefing:

  • Lens Technology A/H Listing – Pricing Looks Decent
  • Lens Technology H Share Listing (6613 HK): The Investment Case
  • Beijing Geekplus Pre-IPO: Expensive Valuation and Mark up from Previous Round
  • Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions
  • Pre-IPO Genuine Biotech – The Current Pipeline Hardly Supports High Valuation


Lens Technology A/H Listing – Pricing Looks Decent

By Sumeet Singh

  • Lens Technology (300433 CH), a precision manufacturing solution provider, aims to raise around US$600m in its H-share listing.
  • Lens Technology (LT) is one of the leading players in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicles interaction systems.
  • We have looked at the past performance and likely A/H premium in our previous note. In this note, we talk about the IPO pricing.

Lens Technology H Share Listing (6613 HK): The Investment Case

By Arun George

  • Lens Technology (6613 HK), an industry-leading integrated one-stop precision manufacturing solution provider, has launched an H Share listing to raise US$600 million.     
  • In terms of revenue in 2024, Lens is a global leader in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicle interaction systems.
  • The investment case is based on a well-performing core business, limited tariff impact, reduced reliance on Apple, strong margins, and robust cash generation. 

Beijing Geekplus Pre-IPO: Expensive Valuation and Mark up from Previous Round

By Nicholas Tan

  • Geek+ (1678559D CH) is looking to raise up to $300m in its upcoming Hong Kong IPO.
  • It is a leader in the global autonomous mobile robots (AMR) market.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions

By Tina Banerjee

  • Wuhan Dazhong Dental Medical launched IPO aiming to raise up to HK$232 million (US$30 million). The company plans to sell 10.8 million shares at HK$20–HK$21.4 per share.
  • Wuhan Dazhong Dental Medical is a private dental services provider in Central China providing dental services under the direct chain model.
  • The IPO price is set at a premium (23%) to the price realized during Series B funding. Valuation looks attractive. But there are a few concerns to take into account.

Pre-IPO Genuine Biotech – The Current Pipeline Hardly Supports High Valuation

By Xinyao (Criss) Wang

  • Essentially, Genuine‘s pipeline and commercialization strategy are centered around azvudine. However, the commercialization would still rely on the indications of HIV infection and COVID-19 in the short term.
  • The COVID-19 has passed, so future revenue contribution of this indication will gradually shrink. Considering the unsustainability of its future performance, we suggest excluding COVID-19 projects when considering long-term valuation.
  • The post-investment valuation after Series B financing was RMB3.56 billion. However, we are conservative about Genuine’s outlook, and we think reasonable valuation could be below RMB2 billion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Lens Technology , Lens Technology, Chow Tai Fook Jewellery, Geek+, Zijin Mining Group , Tencent Music, Midea Group, 3SBio Inc, JD.com , Wuhan Dazhong Dental Medical and more

By | China, Daily Briefs

In today’s briefing:

  • Lens Technology A/H Listing – Pricing Looks Decent
  • Lens Technology H Share Listing (6613 HK): The Investment Case
  • Shortlist Of High Conviction Ideas Across China, Japan, India – June 2025
  • Beijing Geekplus Pre-IPO: Expensive Valuation and Mark up from Previous Round
  • Zijin Mining (601899.SS): Acquires Kazakhstan’s Raygorodok Gold Mine for USD 1.2 Billion
  • Tencent Music (TME): Quick Note – Acquisition of Ximalaya
  • Midea Group(300 HK): Upcoming Spin-Off & IPO of ‘Annto’,Ongoing and Proposed Buyback, Strong Outlook
  • 3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?
  • JD.com (9618 HK) Top Option Trades: Bullish Butterfly Stands Out Amond Bearish Sentiment
  • Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions


Lens Technology A/H Listing – Pricing Looks Decent

By Sumeet Singh

  • Lens Technology (300433 CH), a precision manufacturing solution provider, aims to raise around US$600m in its H-share listing.
  • Lens Technology (LT) is one of the leading players in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicles interaction systems.
  • We have looked at the past performance and likely A/H premium in our previous note. In this note, we talk about the IPO pricing.

Lens Technology H Share Listing (6613 HK): The Investment Case

By Arun George

  • Lens Technology (6613 HK), an industry-leading integrated one-stop precision manufacturing solution provider, has launched an H Share listing to raise US$600 million.     
  • In terms of revenue in 2024, Lens is a global leader in precision structural parts and modules integrated solutions for both consumer electronics and smart vehicle interaction systems.
  • The investment case is based on a well-performing core business, limited tariff impact, reduced reliance on Apple, strong margins, and robust cash generation. 

Shortlist Of High Conviction Ideas Across China, Japan, India – June 2025

By Sreemant Dudhoria,CFA


Beijing Geekplus Pre-IPO: Expensive Valuation and Mark up from Previous Round

By Nicholas Tan

  • Geek+ (1678559D CH) is looking to raise up to $300m in its upcoming Hong Kong IPO.
  • It is a leader in the global autonomous mobile robots (AMR) market.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Zijin Mining (601899.SS): Acquires Kazakhstan’s Raygorodok Gold Mine for USD 1.2 Billion

By Rahul Jain

  • Zijin has acquired one of Kazakhstan’s largest gold mines, Raygorodok, adding 3.2 Moz in reserves and 193 koz in annual production.
  • He asset is highly profitable (USD 202m net profit in 2024) with low costs (USD 796/oz), lifting Zijin’s output by 8% and reserves by 4%.
  • 5.9x P/E and 3.3x EV/EBITDA, the deal looks attractively priced and enhances the scale, margins, and IPO narrative for Zijin Gold International.

Tencent Music (TME): Quick Note – Acquisition of Ximalaya

By Ming Lu

  • TME proposed to acquire 100% shares of Ximalaya, a long audio app.
  • TME has been exploring the long audio market since 2020.
  • We believe Ximalaya has advantages in monthly active users and car radio.

Midea Group(300 HK): Upcoming Spin-Off & IPO of ‘Annto’,Ongoing and Proposed Buyback, Strong Outlook

By Sreemant Dudhoria,CFA

  • Annto IPO: Midea Group (300 HK)plans to spin off its subsidiary Annto Logistics via a domestic IPO to unlock value in its fast-growing logistics platform.
  • Share Buyback:Midea Group Co Ltd A (000333 CH) announced a RMB 5–10 billion A-share buyback in June 2025, signaling confidence and supporting shareholder returns through disciplined capital allocation.
  • B2B Transition: Shifting from a B2C appliance maker to a tech-led B2B solution provider. With B2B contribution over 30% of revenue, it positions it for long-term, higher-margin, solution-led global growth

3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?

By Tina Banerjee

  • 3SBio Inc (1530 HK) signed an outlicensing deal worth more than $6B with Pfizer for its PD-1/VEGF bispecific antibody, SSGJ-707. Since signing the deal, 3SBio shares rallied more than 55%.
  • Considering deals signed with Chinese companies for bispecific antibody drug candidates in recent times, 3SBio seems to have secured best valuation for its asset.
  • Initiation of global trial of SSGJ-707 and data readout from its ongoing China trials for additional indications, continued strong financial performance, and new approvals are upcoming catalysts.

JD.com (9618 HK) Top Option Trades: Bullish Butterfly Stands Out Amond Bearish Sentiment

By Gaudenz Schneider

  • Context: Over the past five trading days, JD.com (9618 HK) multi-leg option strategies showcased a variety of approaches. Strategy highlights are provided.
  • Highlights: Diagonal Spreads continue to enjoy popularity. Plus, an out of the money butterfly at near zero premium demonstrates a creative application of this popular option combination.
  • Why read: This breakdown of complex option strategies sheds light on market sentiment and positioning. Detailed examples provide actionable insights that could inspire similar strategies,

Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions

By Tina Banerjee

  • Wuhan Dazhong Dental Medical launched IPO aiming to raise up to HK$232 million (US$30 million). The company plans to sell 10.8 million shares at HK$20–HK$21.4 per share.
  • Wuhan Dazhong Dental Medical is a private dental services provider in Central China providing dental services under the direct chain model.
  • The IPO price is set at a premium (23%) to the price realized during Series B funding. Valuation looks attractive. But there are a few concerns to take into account.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars